本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

40.61
+1.363.46%
盤前41.190.5800+1.43%04:49 EDT
成交量:81.14萬
成交額:3,276.62萬
市值:23.60億
市盈率:3.65
高:41.10
開:39.35
低:39.35
收:39.25
52周最高:62.58
52周最低:23.42
股本:5,810.15萬
流通股本:5,134.85萬
量比:1.38
換手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):11.13
每股收益(LYR):11.86
淨資產收益率:64.05%
總資產收益率:-25.71%
市淨率:1.72
市盈率(LYR):3.42

資料載入中...

公司資料

公司名字:
Agios Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
2007
員工人數:
487
公司地址:
88 Sidney Street,Cambridge,Massachusetts,United States
郵編:
02139
電話:
傳真:
- -
簡介:
Agios Pharmaceuticals, Inc.於2007年8月7日在特拉華州註冊成立。該公司是一家生物製藥公司,致力於通過細胞代謝領域的領導地位改變患者的生活,目標是為罕見病創造差異化藥物,重點是經典血液學。

董事

名稱
職位
Brian Goff
Chief Executive Officer and Director
Jacqualyn A. Fouse
Chairman of the Board
Catherine Owen
Independent Director
Cynthia Smith
Independent Director
David Scadden
Independent Director
Jeffrey D. Capello
Independent Director
Kaye Foster Cheek
Lead Independent Director
Maykin Ho
Independent Director
Rahul D. Ballal
Independent Director
Jay Backstrom
Director

股東

名稱
職位
Brian Goff
Chief Executive Officer and Director
Cecilia Jones
Chief Financial Officer
James Burns
Chief Legal Officer
Krishnan Viswanadhan
Chief Corporate Development and Strategy Officer
Sarah Gheuens
Chief Medical Officer and Head of Research and Development
T. J. Washburn
Principal Accounting Officer, Vice President and Controller
Tsveta Milanova
Chief Commercial Officer